β¨ Health Notices
2142 NEW ZEALAND GAZETTE, No. 78 20 JUNE 2013
Crown Entities Act 2004
Dated at Wellington this 11th day of June 2013.
HON TONY RYALL, Minister of Health.
go3855
Appointment to the Health Quality & Safety Commission Board
Pursuant to section 28(1)(a) of the Crown Entities Act 2004, the Minister of Health has appointed
Dale Marcus Bramley
as a member of the Health Quality & Safety Commission Board for a three-year term of office commencing on 12 June 2013.
Dated at Wellington this 11th day of June 2013.
HON TONY RYALL, Minister of Health.
go3854
Appointment to Wairarapa District Health Board
Pursuant to section 28(1)(a) of the Crown Entities Act 2004, the Minister of Health has appointed
Ronald Te Aroha Karaitiana
as a member of the board of the Wairarapa District Health Board for a term of office commencing on 12 June 2013 and ending on 8 December 2013.
Health Practitioners Competence Assurance Act 2003
Reappointments/appointments to the New Zealand Podiatrists Board
Pursuant to section 120 of the Health Practitioners Competence Assurance Act 2003, the Minister of Health reappoints
Margaret Moir
Dr Barry Smith
as layperson members; and appoints
Bruce Baxter
Stephen York
as health practitioner members of the New Zealand Podiatrists Board for three-year terms of office commencing on the date of this notification.
Dated at Wellington this 12th day of June 2013.
HON TONY RYALL, Minister of Health.
go3731
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Apo-Candesartan
Active Ingredient: Candesartan cilexetil 4mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Research Private Limited, Bangalore, India
Product: Apo-Candesartan
Active Ingredient: Candesartan cilexetil 8mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Research Private Limited, Bangalore, India
Product: Apo-Candesartan
Active Ingredient: Candesartan cilexetil 16mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Research Private Limited, Bangalore, India
Product: Apo-Candesartan
Active Ingredient: Candesartan cilexetil 32mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Research Private Limited, Bangalore, India
Product: Finasteride Alphapharm
Active Ingredient: Finasteride 5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan LLC, Caguas, Puerto Rico
Next Page →
β¨ LLM interpretation of page content
π₯ Appointment to the Health Quality & Safety Commission Board
π₯ Health & Social Welfare11 June 2013
Appointment, Health Quality & Safety Commission Board, Crown Entities Act 2004
- Dale Marcus Bramley, Appointed member of the Health Quality & Safety Commission Board
- HON TONY RYALL, Minister of Health
π₯ Appointment to Wairarapa District Health Board
π₯ Health & Social Welfare11 June 2013
Appointment, Wairarapa District Health Board, Crown Entities Act 2004
- Ronald Te Aroha Karaitiana, Appointed member of the Wairarapa District Health Board
- HON TONY RYALL, Minister of Health
π₯ Reappointments/appointments to the New Zealand Podiatrists Board
π₯ Health & Social Welfare12 June 2013
Reappointment, Appointment, New Zealand Podiatrists Board, Health Practitioners Competence Assurance Act 2003
- Margaret Moir, Reappointed layperson member of the New Zealand Podiatrists Board
- Barry Smith (Dr), Reappointed layperson member of the New Zealand Podiatrists Board
- Bruce Baxter, Appointed health practitioner member of the New Zealand Podiatrists Board
- Stephen York, Appointed health practitioner member of the New Zealand Podiatrists Board
- HON TONY RYALL, Minister of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines Act 1981, New Medicines, Distribution Consent
- HON TONY RYALL, Minister of Health
NZ Gazette 2013, No 78